ASND Bathi resik saben saham sajrone 12 wulan pungkasan ascendispharma.com

Ascendis Pharma A/S (ASND) faces a fierce race for speed-to-market for drugs within the rare disease niche. The company is currently transitioning toward product commercialization, which ensures financial autonomy. Success is based on the TransCon method and the academic culture of Danish chemists. The rolling earnings per share trend visualizes these processes, while the 13.08 indicator reflects the current dynamics of per-unit income.

ASND (Ascendis) riwayat Bathi resik saben saham (EPS TTM) saka 04.07.2022 nganti 12.11.2026

Rincian analitis lan laporan data perusahaan Ascendis Pharma AS (ASND)

- rega saham lan target rega konsensus:

Rega saham Ascendis Pharma A/S|ASND - Rata-rata rega prakiraan

- data kapitalisasi pasar:

Biji pasar Ascendis Pharma A/S|ASND - Total Nilai Bisnis

- indikator nilai aset resik miturut neraca:

Nilai Buku saben Saham Ascendis Pharma|ASND - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku ascendispharma.com|ASND - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Utang marang Ekuitas Ascendis Pharma A/S|ASND - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas Ascendis Pharma Inc.|ASND - Utang perusahaan|Utang-utang marang kapitalisasi buku Ascendis Pharma A/S|ASND - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Ascendis Pharma|Likuiditas cepet ascendispharma.com

- indikator pendapatan resik lan kelipatan nilai:

ASND - Penghasilan resik|Proyeksi bathi mangsa ngarep Ascendis Pharma A/S|ASND - Pangali P/E|Rega marang bathi mangsa ngarep Ascendis Pharma|ASND - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Ascendis Pharma A/S|ASND - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Ascendis Pharma|ASND - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan ascendispharma.com|ASND - Wutah bathi saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Ascendis Pharma A/S

Pambiji fundamental perusahaan:Ascendis Pharma A/S (ASND)

Ascendis Pharma A/S (ASND) is strengthening its position in the pharmaceutical market by replacing daily therapies with long-acting injections powered by the TransCon platform. The effectiveness of this strategy is quantified through the ratio of net income to the number of shares over a rolling year, which filters out issuance noise and allows for an assessment of real per-share returns based on the net income per share dynamics over the last 12 months.

Pesaing Ascendis Pharma A/S